LEAP THERAPEUTICS, INC. (LPTX) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 17 transactions totaling $40.5M, demonstrating a bullish sentiment with $40.5M in net insider flow. The most recent transaction on Jan 26, 2024 involved a transaction of 7,500 shares valued at $0.
No significant insider buying has been recorded for LPTX in the recent period.
No significant insider selling has been recorded for LPTX in the recent period.
Based on recent SEC filings, insider sentiment for LPTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $40.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at LEAP THERAPEUTICS, INC. (LPTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading LPTX stock, having executed 17 transactions in the past 90 days. The most active insider is Douglas E. Onsi (Executive), who has made 4 transactions totaling $7.4M.
Get notified when executives and directors at LPTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | E. Onsi Douglas | Executive | Option Exercise | 7,500 | $N/A | $0 | |
| Jan 26, 2024 | Lawlor Augustine | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jan 26, 2024 | Sirard Cynthia | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jan 26, 2024 | Mark O'mahony John | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Jan 26, 2024 | Mirabelli Christopher | Executive | Option Exercise | 5,000 | $N/A | $0 | |
| Mar 17, 2023 | E. Onsi Douglas | Executive | Option Exercise | 660,606 | $N/A | $0 | |
| Sep 24, 2021 | Beigene, Ltd. | Executive | Purchase | 2,543,800 | $2.85 | $7.2M | Large |
| Dec 28, 2020 | Viii, L.p. Healthcare Partners | Executive | Other | 2,618,406 | $N/A | $0 | |
| Jun 22, 2020 | Sciences Master Fund Ltd Perceptive Life | Executive | Purchase | 1,750,000 | $2.00 | $3.5M | Large |
| Feb 5, 2019 | Ix, L.p. Healthcare Ventures | Executive | Purchase | 571,428 | $1.75 | $1000.0K | Large |
| Feb 5, 2019 | Mirabelli Christopher | Executive | Purchase | 571,428 | $1.75 | $1000.0K | Large |
| Feb 5, 2019 | Lawlor Augustine | Executive | Purchase | 571,428 | $1.75 | $1000.0K | Large |
| Feb 5, 2019 | E. Onsi Douglas | Executive | Purchase | 571,428 | $1.75 | $1000.0K | Large |
| Nov 14, 2017 | Mirabelli Christopher | Executive | Purchase | 1,057,769 | $6.09 | $6.4M | Large |
| Nov 14, 2017 | Lawlor Augustine | Executive | Purchase | 1,057,769 | $6.09 | $6.4M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $40.5M | 100.0% |
Exercise(M) | 6 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at LEAP THERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 10 insiders making 17 transactions totaling $40.5M in purchases versus $0 in sales, the net buying activity of $40.5M signals strong executive confidence. Douglas E. Onsi (Executive) leads the buying activity with $7.4M in transactions across all time.